| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |